Back to results
US 11,648,239 B2Granted
Azophenols as ERG oncogene inhibitors
AssigneeThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
InventorsAlbert L. Dobi, Clifton L. Dalgard, Shiv K. Srivastava
Life of this patent
Estimating the term…
Abstract
Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
Claims10
A pharmaceutical composition comprising a compound selected from:
- or a pharmaceutically acceptable salt thereof,
- and an excipient.
Dependencies are inferred from the claim text.